Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9962616 | 0.88 | GAA (0.48) | GAAMAPK1TSHRXDHMEN1 | |
| SCHEMBL16690170 | 0.86 | MAPK1 (0.53) | GAAMAPK1TSHRXDHCES1 | |
| SCHEMBL9962608 | 0.83 | SRD5A2 (0.55) | GAAMAPK1TSHRXDHCES1 | |
| SCHEMBL9962625 | 0.82 | MAPK1 (0.49) | GAAMAPK1TSHRXDHCES1 | |
| SCHEMBL267670 | 0.82 | CES1 (0.51) | GAAMAPK1CES1MEN1KMT2A | |
| SCHEMBL12287279 | 0.81 | LMNA (0.43) | GAAMAPK1XDHMEN1KMT2A | |
| SCHEMBL13192526 | 0.79 | XDH (0.47) | MAPK1TSHRXDHCES1MEN1 | |
| SCHEMBL27852524 | 0.78 | MAPK1 (0.58) | GAAMAPK1TSHRCES1MEN1 | |
| SCHEMBL10903672 | 0.78 | MAPT (0.52) | GAAMAPK1TSHRMEN1KMT2A | |
| SCHEMBL5313736 | 0.77 | NPC1 (0.63) | GAAMAPK1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2223910-B1 | OXIME ESTERS AND PHOTOPOLYMERIZATION INITIATORS CONTAINING THE SAME | ADEKA CORP (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-8202679-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202679-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20100249262-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100249262-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-2223910-A1 | OXIME ESTERS AND PHOTOPOLYMERIZATION INITIATORS CONTAINING THE SAME | Adeka Corporation (JP) | 2010-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249262-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | OXER1, CYP4A11, NR2E3 | GAA 4808/4885MAPK1 1665/4885TSHR 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.